Pursue Wealth Partners LLC Grows Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Pursue Wealth Partners LLC grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,804 shares of the exchange traded fund’s stock after acquiring an additional 1,227 shares during the period. Pursue Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,463,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the business. Affinity Asset Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 105.4% in the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after purchasing an additional 737,550 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after purchasing an additional 730,000 shares during the last quarter. Mirae Asset Securities USA Inc. purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $55,626,000. Jane Street Group LLC increased its holdings in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares during the last quarter. Finally, Baymount Management LP purchased a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $34,160,000.

SPDR S&P Biotech ETF Trading Up 0.6 %

Shares of NYSEARCA:XBI opened at $97.66 on Friday. The company has a market capitalization of $7.44 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50-day moving average price of $98.92 and a 200 day moving average price of $94.82. SPDR S&P Biotech ETF has a 12-month low of $64.99 and a 12-month high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.